Saturday, April 01, 2017 9:51:11 PM
Thanks a lot for this! Great share! I would just add to be clear because some may not have been following this terribly closely: imo from reading the complaint this suit was from the start real trash, just a mishmash of verbal diarrhea, not even a coherent set of concrete claims. That is my executive summary of what senti wrote the judge said. It's just a wonder it wasn't dismissed long ago.
The Yonemura suit is at least more coherent. That suit as I read it, really isn't against NWBO so much claims against LP and Cognate that Cognate got unfairly beneficial terms on certain transactions like stock for AP invoices. That suit will be settled but I don't think it goes against NWBO in any way. The settlement might even mean Cognate pays NWBO something.
I hate to sound grouchy but may I make the following request just to add even more value to communications in this group?
If you downloaded the document you are allowed to share it within pacermonitor's terms of use. I think there's an automatic way of sharing that Xena has referenced. There is no need to force others to pay pacermonitor. In future, could you please keep that in mind?
The Yonemura suit is at least more coherent. That suit as I read it, really isn't against NWBO so much claims against LP and Cognate that Cognate got unfairly beneficial terms on certain transactions like stock for AP invoices. That suit will be settled but I don't think it goes against NWBO in any way. The settlement might even mean Cognate pays NWBO something.
I hate to sound grouchy but may I make the following request just to add even more value to communications in this group?
If you downloaded the document you are allowed to share it within pacermonitor's terms of use. I think there's an automatic way of sharing that Xena has referenced. There is no need to force others to pay pacermonitor. In future, could you please keep that in mind?
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
